Monoclonal antibody with specificity for SARS-CoV-2 RBD

The present invention relates to monoclonal antibodies that bind to the receptor binding domain of the spike protein of the SARS-CoV-2 virus, nucleic acids encoding the antibodies, host cells producing the antibodies, compositions and kits comprising the antibodies, and methods of using the same. Co...

Full description

Saved in:
Bibliographic Details
Main Authors GERG MICHAEL, KURTKAYA ULRIKE, JURKNISCHKE, UWE, STIGLER, STEPHEN, C, CHOWHUM SAPTARSHI, SCHREMM MICHAEL
Format Patent
LanguageChinese
English
Published 02.08.2024
Subjects
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to monoclonal antibodies that bind to the receptor binding domain of the spike protein of the SARS-CoV-2 virus, nucleic acids encoding the antibodies, host cells producing the antibodies, compositions and kits comprising the antibodies, and methods of using the same. Comprising a method for detecting the SARS-CoV-2 virus in a sample by using the antibody and a method for using the antibody in an immunoassay. 本发明涉及结合至SARS-CoV-2病毒的刺突蛋白的受体结合结构域的单克隆抗体、编码所述抗体的核酸、产生所述抗体的宿主细胞、包含所述抗体的组合物和试剂盒，包括使用所述抗体的检测样品中SARS-CoV-2病毒的方法以及在免疫测定中使用所述抗体的方法。
Bibliography:Application Number: CN20228071978